期刊文献+

反义Cyclin B1提高Lewis肺癌细胞对健择化学敏感性的体内外研究 被引量:2

Effect of Full-length Cyclin B1 Antisense cDNA on Chemosensitivity of Lewis Lung Carcinoma Cells to Gemicitabine in vitro and in vivo
下载PDF
导出
摘要 目的研究CyclinB1反义全长cDNA(AS-CLB1)对小鼠Lewis肺癌细胞(LL/2)化疗敏感性的影响,为将该方法联合健择化疗用于非小细胞肺癌的治疗提供实验依据。方法通过流式细胞术检测LL/2亲本(LP),LL/2空载体(LV)及LL/2/AS-CLB1(LA)细胞的凋亡及细胞周期分布。用健择(20nmol/L~20μmol/L)处理上述三种细胞,分别于1h及24h后用四甲基偶氮唑盐(MTT)比色法评估健择对各组细胞的体外杀伤作用。将上述三种细胞分别接种C57BL/6小鼠,成瘤后用健择〔25~125mg/(kg·d)〕处理各组动物,3d1次,一共4次,观察细胞在体内的成瘤性及动物的生存时间,并用流式细胞仪检测各组动物肿瘤组织的细胞凋亡。结果LA细胞较对照(LP和LV细胞)出现了明显的G1期阻滞及凋亡;健择对LA细胞的体外杀伤作用显著增强;在LA细胞组,细胞的成瘤性明显下降,该组动物肿瘤组织的细胞凋亡明显增加,动物的生存时间也显著延长。结论AS-CLB1可以明显增强LL/2细胞体内外对健择的化学敏感性,其作用可能与AS-CLB1诱导细胞发生G1期阻滞及凋亡,从而增强了健择的抗肿瘤作用有关。 Objective To evaluate the effect of full-length cyclin B1 antisense cDNA (AS-CLB1) on chemosensitivity of Lewis lung carcinoma cells (LL/2) to gemicitabine (GEM) in vitro and in vivo and hence provide a therapeutic regiment for treating non-small cell lung (NSCL) cancer using AS-CLB1 combined with GEM. Methods Cell cycle phase distribution and apoptosis of LL/2 parent cells, LL/2/vect and LL/2/AS-CLB1 transfectants (LP, LV and LA cells) were determined by flow cytometry. In addition, the three kinds of cells were treated with GEM (20 nmol/L-20 μmol/L) in vitro for 1 h and 24 h respectively, and then cytotoxicity of GEM was measured by MTT assay. After inoculation with the three kinds of cells respectively, the C57BL/6 mice were treated with GEM 〔25 125 mg/(kg·day)〕 once every three days for four times when tumors developed; tumorigenicity and survival were observed and cell apoptosis in tumor tissues was determined by flow cytometry. Results LA cells displayed apparent apoptosis and G_1 arrest compared with LP and LV cells (controls). Additionally, cytotoxicity of GEM to LA cells was more obvious than that to controls. Moreover, tumorigenicity was inhibited, cell apoptosis in tumor tissues was induced, and survival was evidently increased in LA cells group. Conclusion AS-CLB1 slightly increased the sensitivity of LL/2 cells to GEM in vitro and in vivo. The function of AS-CLB1 may be associated with its ability to enhance the anti-tumor activity of GEM by inducing cell apoptosis and G_1 arrest.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2005年第4期464-467,474,共5页 Journal of Sichuan University(Medical Sciences)
基金 国家973计划(编号2004CB518800 2001CB510001)资助
关键词 化学敏感性 反义CDNA 细胞周期蛋白B1 健择 LEWIS肺癌细胞 Chemosensitivity Antisense cDNA Cyclin B1 Gemicitabine Lewis lung carcinoma cells
  • 相关文献

参考文献12

  • 1O'Connor PM, Ferris DK, White GA, et al. Relationships between cdc2 kinase, DNA cross-linking, and cell cycle perturbations induced by nitrogen mustard. Cell Growth Differ,1992;3(1):43.
  • 2Porter LA, Singh G, Lee JM. Abundance of cyclin B1 regulates γ-radiation-induced apoptosis. Blood,2000;95(8):2645.
  • 3Soria JC, Jang SJ, Khuri FR, et al. Over expression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication. Cancer Res,2000;60(15):4000.
  • 4Manegold C. Gemcitabine (Gemzar) in non-small cell lung cancer. Expert Rev Anticancer Ther,2004;4(3):345.
  • 5Lee WP, Tai DI, Tsai SL, et al. Adenovirus type 5 E1A sensitizes hepatocellular carcinoma cells to gemcitabine. Cancer Res, 2003;63(19):6229.
  • 6Hopkins-Donaldson S, Cathomas R, Sim?es-Wüst AP, et al. Induction of apoptosis and chemosensitization of mesothelioma cells by Bcl-2 and Bcl-xL antisense treatment. Int J Cancer, 2003;106(2):160.
  • 7Morris MC, Chaloin L, Choob M, et al. Combination of a new generation of PNAs with a peptide-based carrier enables efficient targeting of cell cycle progression. Gene Ther, 2004;11(9): 757.
  • 8Yuan J, Yan R, Kramer A, et al. Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells. Oncogene, 2004;23(34):5843.
  • 9Shi Z, Azuma A, Sampath D, et al. S-Phase arrest by nucleoside analogues and abrogation of survival without cell cycle progression by 7-hydroxystaurosporine. Cancer Res, 2001;61(3):1065.
  • 10Renner K, Amberger A, Konwalinka G, et al. Changes of mitochondrial respiration, mitochondrial content and cell size after induction of apoptosis in leukemia cells. Biochim Biophys Acta, 2003;1642(1-2):115.

同被引文献17

  • 1金正均.合并用药中的相加[J].中国药理学报,1980,1:70-73.
  • 2Soria JC et al.Cancer Res,2000,60:4000.
  • 3Porter LA et al.Blood,2000,95:2645.
  • 4Agrawal S et al.Curr Opin Chem Biol,1998,2:519.
  • 5Weiss B et al.Cell Mol Life Sci,1999,55:334.
  • 6Kornmann M et al.J Clin Invest,1998,101:344.
  • 7张伶等.华西口腔医学杂志,2005,23:80-80.
  • 8Lee WP et al.Cancer Res,2003,63:6229.
  • 9张伶等.细胞生物学杂志,2006,28:701-701.
  • 10萨姆布鲁克等.分子克隆实验指南,第3版,北京:科学出版社,2002.

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部